Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy
Cancer Treatment and Research Communications(2022)
摘要
•The role of tumor angiogenesis in tumor growth, metastasis, and drug resistance.•VEGF, VEGFRs, and their inhibitors could glean newer options such as vascular normalization, to enhance anti-angiogenic cancer therapy.•The vascular normalization therapy could be a promising strategy in combating cancer.
更多查看译文
关键词
Cancer,Tumour blood vessels,Angiogenesis,Vascular endothelial growth factor (VEGF),Anti-angiogenic therapy,Vascular normalization therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要